Cabazitaxel is more active than first-generation taxanes in ABCB1(+) cell lines due to its reduced affinity for P-glycoprotein CANCER CHEMOTHERAPY AND PHARMACOLOGY Duran, G. E., Derdau, V., Weitz, D., Philippe, N., Blankenstein, J., Atzrodt, J., Semiond, D., Gianolio, D. A., Mace, S., Sikic, B. I. 2018; 81 (6): 1095–1103

View details for DOI 10.1007/s00280-018-3572-1

View details for Web of Science ID 000433507600015